Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
13.1M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
737K
-
Shares change
-
+730K
-
Total reported value, excl. options
-
$4.12M
-
Value change
-
+$4.08M
-
Number of buys
-
21
-
Price
-
$5.59
Significant Holders of Forte Biosciences, Inc. - Common Stock, $0.001 par value (FBRX) as of Q3 2024
23 filings reported holding FBRX - Forte Biosciences, Inc. - Common Stock, $0.001 par value as of Q3 2024.
Forte Biosciences, Inc. - Common Stock, $0.001 par value (FBRX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 737K shares
of 13.1M outstanding shares and own 5.64% of the company stock.
Largest 10 shareholders include TYBOURNE CAPITAL MANAGEMENT (HK) LTD (145K shares), BVF INC/IL (119K shares), PERCEPTIVE ADVISORS LLC (95.7K shares), FRED ALGER MANAGEMENT, LLC (82.7K shares), Cable Car Capital LLC (81.3K shares), FARALLON CAPITAL MANAGEMENT LLC (72.4K shares), BML Capital Management, LLC (70.5K shares), VANGUARD GROUP INC (26.4K shares), GEODE CAPITAL MANAGEMENT, LLC (14.3K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (13.1K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.